Biometric Measurement Device Manufacturing

Company

We support personalized healthcare services
through the integration of biosignal
measurement technology and AI.

Our Journey

Since its establishment in 2016, SCI has continued to drive technological innovation.
Based on software and AI·data-driven convergence technologies,
we have built differentiated R&D capabilities,
creating new value in the field of digital healthcare.

2025

Approved for exploratory clinical trials by the Ministry of Food and Drug Safety (MFDS)
Certified for Digital Medical Device GMP compliance
(Digital Medical Device Software (AI/ML), Medical Device Hardware)
Selected for the Gwangju Dong-gu Healthcare Startup Support Program
Selected for the Deep Tech TIPS Global Marketing Program
Obtained manufacturing certification for a Class II medical device (Pulse Rate Monitor)
Patent registered (Blood glucose and blood pressure measurement device using a PPG sensor)

2024

Certified for Medical Device GMP compliance
Obtained manufacturing approval for a Class II medical device (Ballistocardiograph)
Licensed as a medical device manufacturer
Secured investment from Korea SMEs and Startups Agency (KOSME)

2023

Selected for the R&D Special Zone Promotion Program (Research Institute R&D Project)
Selected for the Deep Tech TIPS Program (KRW 1.5 billion over 3 years)
Conducted an analytical clinical study on a PPG-based blood glucose monitoring system
Designated as a Venture Nara product by the Public Procurement Service (EDL-1004)
Completed clinical trials for a Class II medical device (Ballistocardiograph)
KC certification for a non-invasive AI-based healthcare support device
Filed patent application for a PPG-based glucose and blood pressure monitoring device for pets
Registered patent for a blood pressure measurement device using ballistocardiography and AI technology

2021-22

Secured investment from the Jeonnam Angel Investment Matching Fund
Registered a patent for a fall prediction method using ballistocardiography and camera-based sensing
Achieved ISO 13485 certification for ballistocardiography devices and healthcare solutions
Registered a patent for a diabetes prediction method and system using ballistocardiography signals
Registered a patent for an arrhythmia prediction method and system using ballistocardiography signals
Registered a patent for a hypertension prediction method and system using machine learning
Relocated headquarters from Jangseong to Gwangju
Published a research paper on glucose level prediction using PPG and machine learning
Selected as a Kibo-Star Valley company

2017-18

Relocated headquarters from Gwangyang to Jangseong
Registered a patent for a non-contact biosignal-based patient monitoring method
Registered a patent for a fall prevention bed
Registered a patent for a smart pillow system

2016

Founded Software Convergence Institute Co., Ltd.
Developed the EDL-1004 pilot system

Business Name Software Convergence Institute CEO Park Cheol Gu
Head Office (61008) 333, Cheomdan-gwagi-ro, Buk-gu, Jeonnam-Gwangju, Republic of Korea Branch Office 3F, 190 Guseong-ro, Dong-gu, Jeonnam-Gwangju, Republic of Korea (183-1, Geumnam-ro 5-ga)
Hong Kong Branch Office Unit 1603, 16/F, The L. Plaza, 367–375 Queen’s Road Central, Sheung Wan, Hong Kong
E-commerce Registration Number 2024-Gwangju/Buk-gu-0441 Business Registration Number 758-87-00323
TEL: +82 - 1600-0415 Email pck3867@scikorea.co.kr

Business Name Software Convergence Institute CEO Park Cheol Gu
Head Office 333, Cheomdan-gwagi-ro, Buk-gu, Jeonnam-Gwangju, Business Development Building 2, Room 205-2, Republic of Korea
Branch Office 3F, 190 Guseong-ro, Dong-gu, Jeonnam-Gwangju, Republic of Korea (183-1, Geumnam-ro 5-ga)
Hong Kong Branch Office Unit 1603, 16/F, The L. Plaza, 367–375 Queen’s Road Central, Sheung Wan, Hong Kong
E-commerce Registration Number 2024-Gwangju/Buk-gu-0441
Business Registration Number 758-87-00323

TEL: +82 - 1600-0415 Email pck3867@scikorea.co.kr